Global Chloroquine Phosphate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chloroquine Phosphate Market Research Report 2024
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
According to Mr Accuracy reports’s new survey, global Chloroquine Phosphate market is projected to reach US$ 58 million in 2034, increasing from US$ 136 million in 2022, with the CAGR of -11.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chloroquine Phosphate market research.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chloroquine Phosphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV
Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Malaria
COVID-19
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chloroquine Phosphate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source![](http://localhost/mraccuracy/images/About Report.webp)
According to Mr Accuracy reports’s new survey, global Chloroquine Phosphate market is projected to reach US$ 58 million in 2034, increasing from US$ 136 million in 2022, with the CAGR of -11.4% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chloroquine Phosphate market research.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chloroquine Phosphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV
Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Segment by Application
Malaria
COVID-19
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chloroquine Phosphate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
![](http://localhost/mraccuracy/images/About Report.webp)